𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P1-375 Functional benefits of memantine treatment for patients with moderate to severe Alzhemier's disease

✍ Scribed by Yvonne Wirth; Rachelle S. Doody; Frederick A. Schmitt; Hans J. Möbius

Book ID
117413248
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
167 KB
Volume
25
Category
Article
ISSN
0197-4580

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolerability of switching from donepezil
Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease
✍ Gunhild Waldemar; Maritta Hyvärinen; Mette Krog Josiassen; Alex Kørner; Heikki L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving